The relationship between estimated sodium and potassium excretion and subsequent renal outcomes.

[1]  S. Yusuf,et al.  Sodium intake and renal outcomes: a systematic review. , 2014, American journal of hypertension.

[2]  G. Heinze,et al.  Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. , 2013, JAMA internal medicine.

[3]  C. Figueroa,et al.  Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria. , 2013, American journal of physiology. Renal physiology.

[4]  I. D. de Boer,et al.  Original Report: Patient-oriented, Translational Research Association between Dietary Sodium and Potassium Intake with Chronic Kidney Disease in Us Adults: a Cross-sectional Study , 2022 .

[5]  Lee Hooper,et al.  Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[6]  Giuseppe Remuzzi,et al.  Sodium intake, ACE inhibition, and progression to ESRD. , 2012, Journal of the American Society of Nephrology : JASN.

[7]  S. Yusuf,et al.  Urinary sodium and potassium excretion and risk of cardiovascular events. , 2011, JAMA.

[8]  M. Hayashi,et al.  Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease , 2011, Clinical and Experimental Nephrology.

[9]  D. Gordin,et al.  The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes , 2011, Diabetes Care.

[10]  S. Yusuf,et al.  Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies , 2011, Circulation.

[11]  S. Yusuf,et al.  Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. , 2011, Archives of internal medicine.

[12]  B. Pitt,et al.  Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[13]  K. Sakai,et al.  [Salt intake and the progression of renal failure in patients with chronic kidney disease]. , 2010, Nihon Jinzo Gakkai shi.

[14]  Salim Yusuf,et al.  The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. , 2009, American heart journal.

[15]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[16]  S. Yusuf,et al.  Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2008, The Lancet.

[17]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[18]  E. Schiffrin,et al.  Chronic Kidney Disease: Effects on the Cardiovascular System , 2007, Circulation.

[19]  T. Sugawara,et al.  Effectiveness of a Spot Urine Method in Evaluating Daily Salt Intake in Hypertensive Patients Taking Oral Antihypertensive Drugs , 2006, Hypertension Research.

[20]  Bruce Kupelnick,et al.  K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .

[21]  G. Navis,et al.  The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  R. Minutolo,et al.  Salt Intake and Renal Outcome in Patients with Progressive Renal Disease , 1998, Mineral and Electrolyte Metabolism.

[23]  H. Lin,et al.  Potassium's cardiovascular protective mechanisms. , 1995, The American journal of physiology.

[24]  K. Itoh,et al.  A SIMPLE METHOD FOR ESTIMATING 24 H URINARY SODIUM AND POTASSIUM EXCRETION FROM SECOND MORNING VOIDING URINE SPECIMEN IN ADULTS , 1993, Clinical and experimental pharmacology & physiology.

[25]  B. Patwardhan,et al.  Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. , 1990, BMJ.

[26]  N. Markandu,et al.  Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? , 1985, British medical journal.

[27]  C. Dollery,et al.  Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diuretic. , 1985, Annals of clinical research.

[28]  R. Sloan,et al.  Estimating Dietary Sodium Intake in Individuals Receiving a Randomly Fluctuating Intake , 1982, Hypertension.

[29]  W. G. Walker,et al.  Plasma aldosterone regulation in anephric man. , 1973, Kidney international.